GleamWall
中文EN

LMMY Exousia Bio, Inc.

Services-Educational Services · OTC · SEC CIK 1939937 · Fiscal year ends 05/31

Financial factors as of 2026-02-28 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-100.0%
TTM net income YoY-148.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-0.7%
ROA-0.7%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets1.2%
Debt / equity0.00x
Current ratio0.00x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-2.36x
Accruals ratio-2.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-02-282026Q22025-11-302026Q12025-08-312025Q4*2025-05-312025Q32025-02-282025Q22024-11-302025Q12024-08-312024Q4*2024-05-31
Income statement
Revenue$0$0$0$0$0$0$3,750$3,750
Cost of revenue$62,108$62,108$0$7,251$0$0$0—
Gross profit-$62,108-$62,108$0-$7,251$0$0$3,750-$5,917
SG&A expense$0$0—-$7,214$6,981$6,981$8,091-$228
Operating income-$237,005-$237,005-$31,814—$6,981$6,981-$4,342—
Pretax income-$19,083-$19,083-$31,814-$3,500$80,129$80,129-$3,911-$5,253
Income tax$0$0$0$0$0$0$0$0
Net income-$19,083-$19,083-$31,814-$3,500$80,129$80,129-$3,911-$5,253
EBITDA—-$236,437-$31,814—$6,981$8,239-$666—
EPS (basic)0.000.000.00—0.010.010.00—
EPS (diluted)0.000.000.00—0.010.010.00—
Weighted avg. shares (diluted)16.76M16.76M7.78M—7.78M7.78M7.78M—
Balance sheet
Cash & equivalents$0$0$0$0$1,028$1,028$1,028$1,028
Receivables$0$0$0$0$0$15,250$15,250$11,500
Current assets$0$0$0$0$0$17,717$17,145$12,964
PP&E, net$670$670$0$0$0$2,435$3,693$4,952
Intangibles$0$0$0$0$0$4,703$7,120$9,537
Total assets$22.05M$22.05M$0$0$0$24,854$27,958$27,453
Current liabilities$261,023$261,023$35,314$0$0$0$17,169$14,169
Total liabilities$261,023$261,023$35,314$0$0$0$86,764$82,348
Shareholders' equity$21.79M$21.79M-$35,314$0$24,854$24,854-$58,805-$54,895
Shares outstanding70.00M70.00M7.78M7.78M7.78M7.78M7.78M7.78M
Cash flow statement
Operating cash flow$0$173,126$3,500-$3,500-$87,566$87,954-$3,676-$1,414
Capital expenditure$0———$0———
Free cash flow$0———-$87,566———
Investing cash flow$0-$22.05M$0$0$0$0$3,676$0
Financing cash flow$0$21.88M-$3,500$3,500$86,538-$87,954$0$1,416
Depreciation & amortization$0$568$0$3,775$0$1,258$3,676$1,258

Free plan shows the latest 8 periods; Pro shows all 16 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.